المؤلفون: Biehl, João Guilherme.

المساهمون: Eskerod, Torben, 1960-

مصطلحات موضوعية: Antiviral Agents -- therapeutic use., Biotechnology -- economics., Cost Control -- economics., Acquired Immunodeficiency Syndrome -- drug therapy., Antiviral Agents -- economics., Public Policy., AIDS (Disease) -- Patients -- Care -- Brazil., AIDS (Disease) -- Patients -- Brazil., AIDS (Disease) -- Political aspects -- Brazil., AIDS (Disease) -- Treatment -- Brazil., AIDS activists -- Brazil., Medical care -- Political aspects -- Brazil., Medical care -- Brazil., AIDS (Disease) -- Social aspects -- Brazil.

جغرافية الموضوع: Brazil.

المؤلفون: Marshall, Alison D., Cunningham, Evan B., Nielsen, Stine, Aghemo, Alessio, Alho, Hannu, Backmund, Markus, Bruggmann, Philip, Dalgard, Olav, Seguin-Devaux, Carole, Flisiak, Robert, Foster, Graham R., Gheorghe, Liana, Goldberg, David, Goulis, Ioannis, Hickman, Matthew, Hoffmann, Patrick, Jancorienė, Ligita, Jarcuska, Peter, Kåberg, Martin, Kostrikis, Leondios G., Makara, Mihály, Maimets, Matti, Marinho, Rui Tato, Matičič, Mojca, Norris, Suzanne, Ólafsson, Sigurður, Øvrehus, Anne, Pawlotsky, Jean-Michel, Pocock, James, Robaeys, Geert, Roncero, Carlos, Simonova, Marieta, Sperl, Jan, Tait, Michele, Tolmane, Ieva, Tomaselli, Stefan, van der Valk, Marc, Vince, Adriana, Dore, Gregory J., Lazarus, Jeffrey V., Grebely, Jason, International Network on Hepatitis in Substance Users (INHSU)

المساهمون: Kostrikis, Leondios G. [0000-0002-5340-7109], Infectious diseases, AII - Infectious diseases, AII - Amsterdam institute for Infection and Immunity, APH - Digital Health, APH - Personalized Medicine, APH - Global Health

المصدر: The Lancet. Gastroenterology & Hepatology
Lancet Gastroenterol Hepatol
lancet. Gastroenterology & hepatology, 3(2), 125-133. Elsevier Limited
Marshall, A D, Cunningham, E B, Nielsen, S, Aghemo, A, Alho, H, Backmund, M, Bruggmann, P, Dalgard, O, Seguin-Devaux, C, Flisiak, R, Foster, G R, Gheorghe, L, Goldberg, D, Goulis, I, Hickman, M, Hoffmann, P, Jancorienė, L, Jarcuska, P, Kåberg, M, Kostrikis, L G, Makara, M, Maimets, M, Marinho, R T, Matičič, M, Norris, S, Ólafsson, S, Øvrehus, A, Pawlotsky, J-M, Pocock, J, Robaeys, G, Roncero, C, Simonova, M, Sperl, J, Tait, M, Tolmane, I, Tomaselli, S, van der Valk, M, Vince, A, Dore, G J, Lazarus, J V, Grebely, J & International Network on Hepatitis in Substance Users (INHSU) 2018, ' Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe ', The Lancet Gastroenterology & Hepatology, vol. 3, no. 2, pp. 125-133 . https://doi.org/10.1016/S2468-1253(17)30284-4
Marshall, A D, Cunningham, E B, Nielsen, S, Aghemo, A, Alho, H, Backmund, M, Bruggmann, P, Dalgard, O, Seguin-Devaux, C, Flisiak, R, Foster, G R, Gheorghe, L, Goldberg, D, Goulis, I, Hickman, M, Hoffmann, P, Jancorienė, L, Jarcuska, P, Kåberg, M, Kostrikis, L G, Makara, M, Maimets, M, Marinho, R T, Matičič, M, Norris, S, Ólafsson, S, Øvrehus, A, Pawlotsky, J-M, Pocock, J, Robaeys, G, Roncero, C, Simonova, M, Sperl, J, Tait, M, Tolmane, I, Tomaselli, S, van der Valk, M, Vince, A, Dore, G J, Lazarus, J V, Grebely, J 2018, ' Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe ', Lancet Gastroenterology and Hepatology, vol. 3, no. 2, pp. 125–133 . https://doi.org/10.1016/S2468-1253(17)30284-4

مصطلحات موضوعية: hepatitis C virus, HIV Infections, chemistry.chemical_compound, 0302 clinical medicine, Antiviral Agents/economics, HIV-HCV co-infection, 030212 general & internal medicine, Reimbursement, liver fibrosis, media_common, Dasabuvir, Coinfection, Health Policy, Gastroenterology, Hepatitis C, 3. Good health, Europe, Hepatitis C, Chronic/complications, Insurance, Health, Reimbursement, 030211 gastroenterology & hepatology, Switzerland, medicine.drug, medicine.medical_specialty, HIV Infections/complications, Antiviral Agents, Drug Costs, 03 medical and health sciences, hepatitis C treatment, medicine, Humans, media_common.cataloged_instance, European Union, European union, PWID, Intensive care medicine, Hepatitis, direct-acting antiviral, Hepatology, business.industry, Hepatitis C, Chronic, alcohol use, medicine.disease, reimbursement, Virology, Ombitasvir, chemistry, Paritaprevir, Ritonavir, business, treatment restrictions

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14bff15ad21c3e93fdf786915d0ce23a
https://doi.org/10.1016/s2468-1253(17)30284-4

المؤلفون: Nayagam, Shevanthi, Conteh, Lesong, Sicuri, Elisa, Shimakawa, Yusuke, Suso, Penda, Tamba, Saydiba, Njie, Ramou, Njai, Harr, Lemoine, Maud, Hallett, Timothy B, Thursz, Mark

المساهمون: Commission of the European Communities, Medical Research Council (MRC), Department of Infectious Disease Epidemiology [London] (DIDE), Imperial College London, Barcelona Centre for International Health Research, Hospital Clinic (CRESIB), Universitat de Barcelona (UB), Medical Research Council Unit The Gambia (MRC), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-Institut Pasteur [Paris] (IP)-Conservatoire National des Arts et Métiers [CNAM] (CNAM), HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM)-HESAM Université - Communauté d'universités et d'établissements Hautes écoles Sorbonne Arts et métiers université (HESAM), Centre International de Recherche contre le Cancer - International Agency for Research on Cancer (CIRC - IARC), Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO), We thank the European Commission (FP7) for funding the programme, the Medical Research Council Laboratories, The Gambia Unit, the local ministry of health and social welfare, and the national public health laboratories for supporting the project., We acknowledge the support of the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) who jointly fund (under the MRC/DFID Concordat agreement) the clinical research fellowship that supports SN., We also thank the French Research Agency on HIV/AIDS and viral hepatitis (ANRS) for supporting ML's work within the PROLIFICA project., The PROLIFICA team, All the study participants, and Debbie Garside, the project manager of PROLIFICA, All authors acknowledge the support of the UK National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at Imperial College London for infrastructure support., Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)-Institut Pasteur [Paris]-Conservatoire National des Arts et Métiers [CNAM] (CNAM)

المصدر: e578
e568
The Lancet global health
The Lancet global health, 2016, 4 (8), pp.e568-e578. ⟨10.1016/S2214-109X(16)30101-2⟩
Dipòsit Digital de la UB
Universidad de Barcelona
The Lancet global health, Elsevier, 2016, 4 (8), pp.e568-e578. ⟨10.1016/S2214-109X(16)30101-2⟩
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Adult, Male, MESH: Antiviral Agents / therapeutic use, MESH: Cost-Benefit Analysis / economics, TENOFOVIR DISOPROXIL FUMARATE, Hepatitis B virus, MESH: Antiviral Agents / economics, Cost-Benefit Analysis, Point-of-Care Systems, VIRUS-INFECTION, Antiviral Agents, MESH: Models, Economic, MESH: Hepatitis B virus / immunology, QUALITY-OF-LIFE, HEPATOCELLULAR-CARCINOMA, E-ANTIGEN, Humans, Mass Screening, SUB-SAHARAN AFRICA, health care economics and organizations, TERM-FOLLOW-UP, Public, Environmental & Occupational Health, MESH: Humans, Science & Technology, Hepatitis B Surface Antigens, DISEASE PROGRESSION, MESH: Mass Screening / methods, Gàmbia, MESH: Adult, LIVER-CIRRHOSIS, NATURAL-HISTORY, MESH: Hepatitis B / drug therapy, Hepatitis B, MESH: Male, MESH: Point-of-Care Systems, MESH: Quality-Adjusted Life Years, MESH: Hepatitis B Surface Antigens / blood, MESH: Gambia, Models, Economic, MESH: Hepatitis B / diagnosis, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, Gambia, Quality-Adjusted Life Years, MESH: Female, Life Sciences & Biomedicine

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::efd9503b46a7e7dcea2b456e20926a5c
http://hdl.handle.net/10044/1/33155

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Nevens, Frederik, Colle, Isabelle, Michielsen, Peter, Robaeys, Geert, Moreno, Christophe, Caekelbergh, Karin, Lamotte, Mark, Wyffels, Veronique

المصدر: European journal of gastroenterology & hepatology, 24 (10

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Adult, Antiviral Agents -- economics -- therapeutic use, Belgium, Carcinoma, Hepatocellular -- drug therapy -- economics -- etiology, Cost of Illness, Cost-Benefit Analysis, Female, Follow-Up Studies, Health Care Costs, Hepacivirus, Hepatitis C, Chronic -- complications -- drug therapy -- economics, Hospitalization -- economics -- statistics & numerical data, Humans, Liver Cirrhosis -- drug therapy -- economics -- etiology, Liver Neoplasms -- drug therapy -- economics -- etiology, Liver Transplantation -- economics, Male, Middle Aged, Retrospective Studies, chronic hepatitis C, decompensated cirrhosis, hepatocellular carcinoma, liver transplantation, medical cost, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/156150
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL